Immunoprecise Stock Future Price Prediction

IPA -  USA Stock  

USD 4.14  0.15  3.50%

Immunoprecise Antibodies stock price prediction is an act of determining the future value of Immunoprecise Antibodies shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Immunoprecise Antibodies' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Immunoprecise Antibodies and does not consider all of the tangible or intangible factors available from Immunoprecise Antibodies' fundamental data. We analyze noise-free headlines and recent hype associated with Immunoprecise Antibodies, which may create opportunities for some arbitrage if properly timed.
Please see Immunoprecise Antibodies Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Immunoprecise Antibodies based on different types of headlines from major news networks to social media. The Immunoprecise stock price prediction module provides an analysis of price elasticity to changes in media outlook on Immunoprecise Antibodies over a specific investment horizon.
Wall Street Target Price
EPS Estimate Current Quarter
Quarterly Revenue Growth YOY
Using Immunoprecise Antibodies hype-based prediction, you can estimate the value of Immunoprecise Antibodies from the perspective of Immunoprecise Antibodies response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Immunoprecise Antibodies using Immunoprecise Antibodies' options and short interest. It helps to benchmark the overall future attitude of investors towards Immunoprecise using crowd psychology based on the activity and movement of Immunoprecise Antibodies' stock price.
Immunoprecise Antibodies Current Ratio is projected to increase based on the last few years of reporting. The past year's Current Ratio was at 9.25. The current year Tangible Assets Book Value per Share is expected to grow to 4.00, whereas Book Value per Share is forecasted to decline to 3.25.

Immunoprecise Antibodies Implied Volatility

Immunoprecise Antibodies' implied volatility exposes the market's sentiment of Immunoprecise Antibodies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Immunoprecise Antibodies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Immunoprecise Antibodies stock will not fluctuate a lot when Immunoprecise Antibodies' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Immunoprecise Antibodies. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Immunoprecise Antibodies to buy its stock at a price that has no basis in reality. In that case, they are not buying Immunoprecise because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Immunoprecise Antibodies after-hype prediction price

  $ 4.19  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immunoprecise Antibodies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immunoprecise Antibodies in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
1 Analysts
LowTarget PriceHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunoprecise Antibodies. Your research has to be compared to or analyzed against Immunoprecise Antibodies' peers to derive any actionable benefits. When done correctly, Immunoprecise Antibodies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immunoprecise Antibodies.

Immunoprecise Antibodies After-Hype Price Prediction Density Analysis

As far as predicting the price of Immunoprecise Antibodies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Immunoprecise Antibodies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Immunoprecise Antibodies, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Immunoprecise Antibodies Estimiated After-Hype Price Volatility

In the context of predicting Immunoprecise Antibodies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Immunoprecise Antibodies' historical news coverage. Immunoprecise Antibodies' after-hype downside and upside margins for the prediction period are 0.21 and 8.95, respectively. We have considered Immunoprecise Antibodies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 4.14
After-hype Price
Immunoprecise Antibodies is moderately volatile asset. Analysis and calculation of next after-hype price of Immunoprecise Antibodies is based on 3 months time horizon.

Immunoprecise Antibodies Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Immunoprecise Antibodies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immunoprecise Antibodies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Immunoprecise Antibodies, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.11  4.76  0.05   0.09  4 Events / Month7 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility 

Immunoprecise Antibodies Hype Timeline

On the 25th of June Immunoprecise Antibodies is traded for 4.14. The entity has historical hype elasticity of 0.05 and average elasticity to hype of competition of 0.09. Immunoprecise is projected to increase in value after the next headline with price projected to jump to 4.19 or above. The average volatility of media hype impact on the company stock price is over 100%. The price jump on the next news is forecasted to be 1.21% whereas the daily expected return is currently at 0.11%. The volatility of related hype on Immunoprecise Antibodies is about 551.35% with expected price after next announcement by competition of 4.23. The company reported the last year's revenue of 19 M. Reported Net Loss for the year was (17.1 M) with profit before taxes, overhead, and interest of 11.4 M. Considering the 90-day investment horizon the next projectedpress releasewill be in about 4 days.
Please see Immunoprecise Antibodies Basic Forecasting Models to cross-verify your projections.

Immunoprecise Antibodies Related Hype Analysis

Having access to credible news sources related to Immunoprecise Antibodies' direct competition is more important than ever and may enhance your ability to predict Immunoprecise Antibodies' future price movements. Getting to know how Immunoprecise Antibodies rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Immunoprecise Antibodies may potentially react to the hype associated with one of its peers.
At Risk
JNJJohnson Johnson 1.00 11 per month 0.91  0.19  2.23 (1.63)  5.06 
TATT Inc 0.21 9 per month 1.37  0.25  2.99 (2.47)  12.23 
WMTWalmart(1.17) 7 per month 0.56  0.34  2.68 (1.71)  8.90 
MCDMcDonalds Corp 1.24 11 per month 1.27  0.16  2.22 (1.98)  7.82 
HDHome Depot 6.30 10 per month 0.00 (0.0277)  2.92 (3.64)  8.63 
VZVerizon Communications 0.49 8 per month 1.69  0.11  2.30 (2.42)  7.94 
BABoeing Company 2.37 10 per month 0.00 (0.07)  5.64 (5.07)  16.31 
VTNRVertex Energy(1.19) 9 per month 5.43  0.13  11.53 (9.66)  30.84 
DISWalt Disney(1.48) 9 per month 0.00 (0.18)  3.29 (3.78)  8.79 

Immunoprecise Antibodies Additional Predictive Modules

Most predictive techniques to examine Immunoprecise price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immunoprecise using various technical indicators. When you analyze Immunoprecise charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Immunoprecise Antibodies Predictive Indicators

The successful prediction of Immunoprecise Antibodies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Immunoprecise Antibodies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Immunoprecise Antibodies based on analysis of Immunoprecise Antibodies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Immunoprecise Antibodies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Immunoprecise Antibodies's related companies.
 2020 2021 2022 (projected)
Book Value per Share3.463.973.25
Asset Turnover0.380.340.36

Story Coverage note for Immunoprecise Antibodies

The number of cover stories for Immunoprecise Antibodies depends on current market conditions and Immunoprecise Antibodies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immunoprecise Antibodies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immunoprecise Antibodies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Immunoprecise Antibodies Short Properties

Immunoprecise Antibodies' future price predictability will typically decrease when Immunoprecise Antibodies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Immunoprecise Antibodies often depends not only on the future outlook of the potential Immunoprecise Antibodies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunoprecise Antibodies' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.24%
Float Shares15.67M
Shares Short Prior Month282.2k
Average Daily Volume Last 10 Day15.05k
Average Daily Volume In Three Month24.92k
Date Short Interest29th of April 2022
Please see Immunoprecise Antibodies Basic Forecasting Models to cross-verify your projections. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
101.5 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.